PERSPECTA

News from every angle

← Back to headlines

I-Mab Biopharma Reports GAAP EPS

I-Mab Biopharma announced its GAAP EPS of -$0.33. This financial report provides insight into the company's performance.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphatpi8d ago

I-Mab Biopharma GAAP EPS of -$0.33

Read full article →

Related Stories

EssilorLuxottica and GCL Announce Share Buyback Programs

3h ago

Michal Strnad Retains Title of Czechia’s Richest Person

7h ago

Warsh Faces Bond Market Pressure Ahead of Jackson Hole Debut

23h ago

U.S. Economy Grows at Sluggish 1.5% Pace in Second Quarter

1d ago